Global Pharmaceuticals & Biotech Profitable Climbers

Alnylam Pharmaceuticals

Market Cap: US$43.8b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Corcept Therapeutics

Market Cap: US$4.2b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Zevra Therapeutics

Market Cap: US$503.3m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Camurus

Market Cap: SEK 40.4b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Rubicon Research

Market Cap: ₹130.2b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Bonesupport Holding

Market Cap: SEK 11.4b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

PharmaEssentia

Market Cap: NT$271.5b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

Anthem Biosciences

Market Cap: ₹356.6b

Operates as technology-focused contract research, development, and manufacturing organization.

ChengDu ShengNuo BiotecLtd

Market Cap: CN¥6.2b

Engages in the research and development, production, sale, and export of peptide drugs.

Xiamen Amoytop Biotech

Market Cap: CN¥28.5b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

Wedge IndustrialLtd

Market Cap: CN¥14.4b

Engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China.

Newron Pharmaceuticals

Market Cap: CHF 377.5m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Alvotech

Market Cap: US$1.6b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

WuXi XDC Cayman

Market Cap: HK$78.2b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Beijing Sun-Novo Pharmaceutical Research

Market Cap: CN¥7.2b

A contract research company, engages in the research and development of drugs in China.

Lotus Pharmaceutical

Market Cap: NT$92.0b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Acutaas Chemicals

Market Cap: ₹162.1b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Pharma Mar

Market Cap: €1.3b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, China, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

Market Cap: ج.م7.0b

Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.

ACADIA Pharmaceuticals

Market Cap: US$4.1b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Kexing Biopharm

Market Cap: CN¥6.0b

A biopharmaceutical company, engages in the research and development, production, and sale of recombinant protein drugs and microecological preparations in China, the European Union, Brazil, the Philippines, and Indonesia.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$32.8b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Hualan Biological Vaccine

Market Cap: CN¥13.5b

Engages in the research and development, production, and sale of vaccines and genetic engineering biological products in China.

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥12.1b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

Boji Medical TechnologyLtd

Market Cap: CN¥4.0b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

Concord Biotech

Market Cap: ₹122.2b

A biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally.

Aether Industries

Market Cap: ₹135.6b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Oncodesign Precision Medicine Société anonyme

Market Cap: €9.8m

A biopharmaceutical company, engages in the precision medicine business.

Kiniksa Pharmaceuticals International

Market Cap: US$3.3b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

Cohance Lifesciences

Market Cap: ₹136.5b

Engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally.

Innova Captab

Market Cap: ₹40.5b

An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.

Orchid Pharma

Market Cap: ₹34.8b

A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.

Eris Lifesciences

Market Cap: ₹195.8b

Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.

CORONA Remedies

Market Cap: ₹93.3b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

Bora Pharmaceuticals

Market Cap: NT$71.1b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

May & Baker Nigeria

Market Cap: ₦63.5b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.